Matches in Wikidata for { <http://www.wikidata.org/entity/Q80365300> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q80365300 description "assaig clínic" @default.
- Q80365300 description "clinical trial" @default.
- Q80365300 description "clinical trial" @default.
- Q80365300 description "clinical trial" @default.
- Q80365300 description "clinical trial" @default.
- Q80365300 description "ensaio clínico" @default.
- Q80365300 description "ensayo clínico" @default.
- Q80365300 description "ensayu clínicu" @default.
- Q80365300 description "essai clinique" @default.
- Q80365300 description "klinisch onderzoek" @default.
- Q80365300 description "клінічне випробування" @default.
- Q80365300 name "Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer" @default.
- Q80365300 name "Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer" @default.
- Q80365300 type Item @default.
- Q80365300 label "Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer" @default.
- Q80365300 label "Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer" @default.
- Q80365300 prefLabel "Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer" @default.
- Q80365300 prefLabel "Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer" @default.
- Q80365300 P1132 Q80365300-32C5CD73-F923-48A8-8A8E-DC099125E24E @default.
- Q80365300 P1476 Q80365300-321DCD48-29C8-48DD-BFF3-F34A949E9F30 @default.
- Q80365300 P17 Q80365300-19269964-8664-4293-9F13-9F8CFA555A39 @default.
- Q80365300 P2899 Q80365300-E67EAD2F-13BE-4ACB-985D-3FD70D3BB25C @default.
- Q80365300 P3098 Q80365300-562ED5EF-FA98-493D-B78F-54B05AA60BA3 @default.
- Q80365300 P31 Q80365300-2D22B9DE-2DDA-4A46-B3EB-9C95E4A11EA5 @default.
- Q80365300 P4844 Q80365300-C1EA89B6-F16C-44E9-B651-694AFA52ED2E @default.
- Q80365300 P580 Q80365300-D35B0FF7-858D-4629-825D-EC053C63EDD8 @default.
- Q80365300 P582 Q80365300-454F85F0-10C8-4A0C-9678-82ED2889650B @default.
- Q80365300 P6099 Q80365300-BECC0C0F-3FDB-4BAB-BB98-22B19B27EB3F @default.
- Q80365300 P8363 Q80365300-67BF5B76-9758-4B2A-AB7C-9E6706FCBC5D @default.
- Q80365300 P1132 "+90" @default.
- Q80365300 P1476 "A Phase Ib/II Study of the Safety and Pharmacology of Nilotinib to Prevent Paclitaxel-Induced Peripheral Neuropathy in Patients With Breast Cancer" @default.
- Q80365300 P17 Q30 @default.
- Q80365300 P2899 "+18" @default.
- Q80365300 P3098 "NCT04205903" @default.
- Q80365300 P31 Q30612 @default.
- Q80365300 P4844 Q423762 @default.
- Q80365300 P580 "2020-01-31T00:00:00Z" @default.
- Q80365300 P582 "2021-12-31T00:00:00Z" @default.
- Q80365300 P6099 Q5452194 @default.
- Q80365300 P8363 Q78089383 @default.